| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/11/1995 | US5432092 C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine |
| 07/11/1995 | US5432091 N-terminal sequencing of proteins and peptides |
| 07/11/1995 | US5432018 Peptide library and screening systems |
| 07/11/1995 | US5431882 Apparatus for collecting peptide fragment |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018228A1 Human circulating cytokine cc-1 |
| 07/06/1995 | WO1995018186A1 Modular design and synthesis of aminimide containing molecules |
| 07/06/1995 | WO1995018155A1 Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it |
| 07/06/1995 | WO1995017950A1 High molecular weight electrodialysis |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | CA2179983A1 Modular design and synthesis of aminimide containing molecules |
| 07/06/1995 | CA2179638A1 Human circulating cytokine cc-1 |
| 07/05/1995 | EP0661647A1 A method and system for modelizing partition functions of sequences |
| 07/05/1995 | EP0661294A1 Cedar pollen protein and uses thereof |
| 07/05/1995 | EP0452514B1 Peptide and process for preparing cyclic peptide |
| 07/05/1995 | CN1104634A Compounds with a sulphamoyl and amidino group, process for preparing them and pharmaceutical compositions containing them |
| 07/04/1995 | US5430099 Immobilized buffered gels and membranes of hydroxy groups containing polymers |
| 07/04/1995 | US5429952 Marking of products to establish identity and source |
| 07/04/1995 | US5429807 Method and apparatus for creating biopolymer arrays on a solid support surface |
| 07/04/1995 | US5429746 Antibody purification |
| 07/04/1995 | CA1336223C Method of chain combination |
| 06/29/1995 | WO1995017671A1 Method for removal of binding proteins from ligands |
| 06/29/1995 | WO1995017518A1 Method for preparing peptide products, and resulting products |
| 06/29/1995 | WO1995017427A1 Acylated protein aggregates and their use in enhancing signals in an immunoassay testing for antibodies |
| 06/29/1995 | WO1995017420A1 Peptide analogs of the activated platelet binding site on factor xi |
| 06/29/1995 | WO1995017413A1 Process for the evolutive design and synthesis of functional polymers based on designer elements and codes |
| 06/29/1995 | WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 06/29/1995 | WO1995017206A1 Lyophilized stem cell factor formulations |
| 06/29/1995 | DE4445517A1 Affinity sepn. method using dynamic filtration device |
| 06/29/1995 | CA2179738A1 Method for preparing peptide products, and resulting products |
| 06/29/1995 | CA2156622A1 Novel human .beta.2 integrin alpha subunit |
| 06/29/1995 | CA2139155A1 Process for preparation of human glicentin |
| 06/28/1995 | EP0659767A1 Process to prepare an anti-D immunoglobulin G concentrate and pharmaceutical compositions comprising it |
| 06/28/1995 | EP0659765A2 Immunoreactive peptides of apo(a) |
| 06/28/1995 | EP0659274A1 Method of sample preparation for urine protein analysis with capillary electrophoresis |
| 06/28/1995 | EP0659213A1 Growth hormone antagonists |
| 06/28/1995 | EP0640095A4 Process for making vancomycin. |
| 06/28/1995 | EP0494268B1 Method for inhibiting growth of stem cells |
| 06/28/1995 | EP0439540B1 Antibody conjugates with two or more covalently linked fc regions |
| 06/28/1995 | EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae |
| 06/28/1995 | EP0432218B1 Method for detecting cellular pathology |
| 06/27/1995 | US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system |
| 06/27/1995 | US5428131 Archaebacterial chaperonin-mediated protein stabilization |
| 06/27/1995 | US5428129 Peptides and processes for producing cyclic peptides |
| 06/27/1995 | US5428128 Forming amino acid chain of polypeptide, conjugating non-antigenic polymer to blocking groups, introducing said polymer at each point of synthesis, continuing synthesis of amino acid chain |
| 06/27/1995 | US5428123 Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
| 06/27/1995 | US5428019 Bombesin analogs |
| 06/27/1995 | US5428018 Phenylalanine analogs of bombesin |
| 06/27/1995 | US5427949 Biosynthetic cerebrospinal fluid control |
| 06/27/1995 | US5427925 Recombniant method for making leukemia inhibitor factor |
| 06/27/1995 | US5427921 Method of preparing yeast extract containing hydrolyzed non-yeast protein with yeast autolytic enzymes |
| 06/27/1995 | US5427918 Incubating plasminogen activator with fibrinogen degradation product containing methionine oxidized to sulfoxide; chromatography |
| 06/27/1995 | CA2032939C Bacterial produced extracts and enzymes for cleavage of organic c-s bonds |
| 06/27/1995 | CA1336119C Vinca derivative conjugates containing a c-3 detergent chain |
| 06/27/1995 | CA1336080C Peptide derivatives, a process for the preparation thereof, and the use thereof |
| 06/27/1995 | CA1336076C Metal radionuclide labeled proteins for diagnosis and therapy |
| 06/24/1995 | CA2127605A1 Affinity separation method |
| 06/22/1995 | WO1995016918A1 Combinatorial libraries and methods for their use |
| 06/22/1995 | WO1995016701A1 Method for purifying polypeptides |
| 06/22/1995 | DE4342560A1 Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics |
| 06/22/1995 | CA2138605A1 Immunoreactive peptides of apo(a) |
| 06/21/1995 | EP0658622A2 Fungi resistant to soraphen A |
| 06/21/1995 | EP0658569A1 Method for decoloring human serum albumin |
| 06/21/1995 | EP0658564A1 Electroluminescent compounds and intermediates in their synthesis |
| 06/21/1995 | EP0658169A1 Diamino acid derivatives as antihypertensives |
| 06/21/1995 | EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 06/21/1995 | EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 06/21/1995 | EP0517831B1 Recovery of protein, protein isolate and/or starch from cereal grains |
| 06/21/1995 | CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition |
| 06/20/1995 | US5426103 Certain macrocyclic lactam derivatives |
| 06/20/1995 | US5426044 Minactivin compositions and antibodies to minactivin |
| 06/20/1995 | US5426031 Extraction methods for preparing thromboplastin reagents |
| 06/20/1995 | US5425787 Method for crystallization of α-L-aspartyl-L-phenylalanine methyl ester |
| 06/20/1995 | CA1336034C Biodegradable polypeptide and the use thereof for the gradual release of drugs |
| 06/18/1995 | CA2138349A1 Method for decoloring human serum albumin |
| 06/15/1995 | WO1995016209A1 Process for the production of combinatorial compound libraries |
| 06/15/1995 | WO1995016030A1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 06/15/1995 | WO1995015969A1 Glycozylhydrazines, preparation, immobilization and reactions of: glycoprotein analysis and o-glycan removal |
| 06/15/1995 | CA2175078A1 Process for the production of combinatorial compound libraries |
| 06/14/1995 | EP0657466A1 A process for refolding of (pro-)chymosin, comprising recycling of urea |
| 06/14/1995 | EP0657416A1 Process for recovering L-phenylalanine |
| 06/14/1995 | EP0656946A1 Immunoglobulins devoid of light chains |
| 06/14/1995 | EP0656907A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 06/14/1995 | EP0656903A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 06/14/1995 | EP0496836B1 Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 06/14/1995 | EP0458841B1 Method for the use and synthesis of peptides |
| 06/13/1995 | US5424402 Non-destructive method for radiolabelling biomolecules by halogenation |
| 06/13/1995 | US5424401 Absorbing enzymatic impurities which has amidolytic and proteolytic activity which degrade the blood factor 8, by pretreating with a solution containg aluminum hydroxide and basic ion exchange resin as absorbents |
| 06/13/1995 | US5424291 Isosteric peptides |
| 06/13/1995 | US5424287 A pure protein-based extract prepared by alkaline extraction a bacterial suspension at a PH between 11 to 13; stimulants for production of prostaglandins, anticarcinogenic agents; immunology |
| 06/13/1995 | US5424186 Very large scale immobilized polymer synthesis |
| 06/13/1995 | US5423966 Selectable meltable plugs that are effective in blocking the passage of analyte species of interest only when solidified; controlled by computer |
| 06/13/1995 | CA1335925C Process for recovering microbially produced interleukin-2 |
| 06/13/1995 | CA1335924C Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus |
| 06/08/1995 | WO1995015335A2 Pretargeting methods and compounds |
| 06/08/1995 | WO1995011912A3 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/08/1995 | CA2177136A1 Pretargeting methods and compounds |
| 06/07/1995 | EP0656419A1 Method of highly purifying human serum albumin |
| 06/07/1995 | EP0656366A1 Iron-lactoferrin combination and process for producing the same |
| 06/07/1995 | EP0598034A4 Production of peptide amides. |